These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 26123313

  • 1. Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies.
    Nishikawa M, Miyake H, Fujisawa M.
    Int J Clin Oncol; 2016 Feb; 21(1):162-7. PubMed ID: 26123313
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
    Nonomura N, Oka D, Nishimura K, Nakayama M, Inoue H, Mizutani Y, Miki T, Okuyama A.
    Int J Urol; 2007 Jun; 14(6):527-31. PubMed ID: 17593098
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Salvage chemotherapy with paclitaxel, ifosphamide and nedaplatin for relapsed or refractory germ cell cancer].
    Nomoto T, Mizutani Y, Mikami K, Nakamura T, Nakanishi H, Kawauchi A, Miki T.
    Nihon Hinyokika Gakkai Zasshi; 2006 May; 97(4):630-5. PubMed ID: 16768143
    [Abstract] [Full Text] [Related]

  • 6. Salvage chemotherapy with docetaxel, ifosfamide and nedaplatin (DIN) for patients with advanced germ cell tumors: a preliminary report.
    Yamada S, Saito H, Ohara S, Yamashita S, Mitsuzuka K, Namiki S, Miyazato M, Kaiho Y, Ito A, Nakagawa H, Ishidoya S, Arai Y.
    Jpn J Clin Oncol; 2013 Jul; 43(7):734-9. PubMed ID: 23619987
    [Abstract] [Full Text] [Related]

  • 7. Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors.
    Miki T, Mizutani Y, Nonomura N, Nomoto T, Nakao M, Saiki S, Kotake T, Okuyama A.
    Cancer; 2002 Nov 01; 95(9):1879-85. PubMed ID: 12404281
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of TIP (paclitaxel, ifosfamide and cisplatin) incorporated into induction chemotherapy for patients with intermediate- or poor-risk metastatic germ cell tumors.
    Nishikawa M, Miyake H, Muramaki M, Fujisawa M.
    Med Oncol; 2014 Dec 01; 31(12):296. PubMed ID: 25341372
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Less nephrotoxicity of paclitaxel and ifosfamide plus nedaplatin for refractory or relapsed germ cell tumors in patients with impaired renal function.
    Shiraishi T, Nakamura T, Takamura T, Oishi M, Yamada T, Yamada Y, Ueda T, Fujihara A, Hongo F, Okihara K, Ukimura O.
    Int J Urol; 2020 Feb 01; 27(2):134-139. PubMed ID: 31701563
    [Abstract] [Full Text] [Related]

  • 11. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
    Park S, Lee S, Lee J, Park SH, Park JO, Kang WK, Park YS, Lim HY.
    Onkologie; 2011 Feb 01; 34(8-9):416-20. PubMed ID: 21934340
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors.
    Feldman DR, Hu J, Dorff TB, Lim K, Patil S, Woo KM, Carousso M, Hughes A, Sheinfeld J, Bains M, Daneshmand S, Ketchens C, Bajorin DF, Bosl GJ, Quinn DI, Motzer RJ.
    J Clin Oncol; 2016 Jul 20; 34(21):2478-83. PubMed ID: 27185842
    [Abstract] [Full Text] [Related]

  • 13. A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.
    Selle F, Wittnebel S, Biron P, Gravis G, Roubaud G, Bui BN, Delva R, Bay JO, Fléchon A, Geoffrois L, Caty A, Soares DG, de Revel T, Fizazi K, Gligorov J, Micléa JM, Dubot C, Provent S, Temby I, Gaulet M, Horn E, Brindel I, Lotz JP.
    Ann Oncol; 2014 Sep 20; 25(9):1775-1782. PubMed ID: 24894084
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach.
    Badreldin W, Krell J, Chowdhury S, Harland SJ, Mazhar D, Harding V, Frampton AE, Wilson P, Berney D, Stebbing J, Shamash J.
    BJU Int; 2016 Mar 20; 117(3):418-23. PubMed ID: 25430674
    [Abstract] [Full Text] [Related]

  • 15. Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.
    Narayan V, Gunnarsson O, Hwang WT, Squillante CM, Nathanson KL, Stadtmauer EA, Vaughn DJ.
    Clin Genitourin Cancer; 2016 Dec 20; 14(6):524-529. PubMed ID: 27083130
    [Abstract] [Full Text] [Related]

  • 16. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M, Miyake H, Hara I, Muramaki M, Takenaka A, Fujisawa M.
    Hinyokika Kiyo; 2007 Dec 20; 53(12):851-6. PubMed ID: 18203521
    [Abstract] [Full Text] [Related]

  • 17. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
    Hartmann JT, Gauler T, Metzner B, Gerl A, Casper J, Rick O, Horger M, Schleicher J, Derigs G, Mayer-Steinacker R, Beyer J, Kuczyk MA, Bokemeyer C, German Testicular Cancer Study Group.
    J Clin Oncol; 2007 Dec 20; 25(36):5742-7. PubMed ID: 18089869
    [Abstract] [Full Text] [Related]

  • 18. Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial.
    Fizazi K, Gravis G, Flechon A, Geoffrois L, Chevreau C, Laguerre B, Delva R, Eymard JC, Rolland F, Houede N, Laplanche A, Burcoveanu D, Culine S.
    Ann Oncol; 2014 May 20; 25(5):987-91. PubMed ID: 24595454
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.
    Harstrick A, Schmoll HJ, Wilke H, Köhne-Wömpner CH, Stahl M, Schöber C, Casper J, Bruderek L, Schmoll E, Bokemeyer C.
    J Clin Oncol; 1991 Sep 20; 9(9):1549-55. PubMed ID: 1651992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.